Searched for
PHARMACEUTICAL CREDIBILITY
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- India Inc wary of fresh trade headwinds as US weighs additional 12.5% tariffThe United States is proposing a 12.5% tariff on Indian imports. This action stems from an investigation into forced labor import prohibiti...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- India should now focus on FTA implementation, utilisation by exporters: ExpertsFor India to leverage its Free Trade Agreements effectively, a paradigm shift in strategy is imperative. Experts caution that the disparity...
- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- India’s realty equity inflows hit record $30.7 billion between 2024-Q1 2026Between 2024 and early 2026, India’s real estate landscape witnessed an astonishing influx of over $30 billion in equity capital, showcasin...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Healthcare, pharma sector to create 2-2.5 million new jobs by 2030: ReportThe country's healthcare and pharmaceutical sector is moving into a capability-led growth phase, with hiring increasingly focused on specia...
- Unconventional ways during war and uncertain times: 4 stocks with dividend yield of up to 5.9%A high dividend yield by itself is not a sign of safety. Sometimes, a stock yields more only because the price has collapsed for a valid re...
- Biggest buying opportunity since Covid may be ahead, says Quant Mutual Fund; deploys cash on attractive valuationsQuant Mutual Fund believes the current market situation presents a major buying chance. The fund house is increasing its investments in sto...
- India’s ‘thin-file’ SMEs need smarter risk models, not more paperwork: Rubix Data Sciences’ Mohan RamaswamyAlternative data and benchmarking are helping lenders assess companies with limited disclosures, says Mohan Ramaswamy, Founder and CEO, Rub...
- Novo Nordisk price cuts set to shake up India’s GLP-1 market, challenge genericsNovo Nordisk is slashing prices for its diabetes and weight loss drugs Ozempic and Wegovy in India. This move aims to make these treatments...
- ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
- New plant of Sun Pharma inaugurated in BangladeshIndian pharmaceutical company, Sun Pharma, inaugurated a new plant in Bangladesh, strengthening economic ties and promoting collaboration i...
- Pharma exports up 9.7 per cent, 33 per cent growth in US markets in FY16Generic drugs form the largest segment, with 75 per cent of market share (in terms of revenues), of the Indian pharmaceutical sector.
Load More
